Ao Yang

Ao Yang is a seasoned professional in the field of structural biology, currently serving as the Director of Structural Biology at Quotient Therapeutics since September 2024. Previously, Ao Yang worked with Ikena Oncology from January 2022 to September 2024 as a Consultant on Drug Discovery and Director of Biomolecular Sciences, leading significant chemical matter discovery initiatives. Ao Yang has held several leadership positions, including Associate Director at Flagship Pioneering, Director of Structural Biology at 1Globe Health Institute, and Director of Structural Biology at Boston Biomedical, Inc. Educational qualifications include a PhD and a Master of Science in Molecular Biophysics from Pierre and Marie Curie University, and a Bachelor of Science in Biological Sciences and Biotechniques from Tsinghua University.